标题
Recent Advances in Desmoid Tumor Therapy
作者
关键词
-
出版物
Cancers
Volume 12, Issue 8, Pages 2135
出版商
MDPI AG
发表日期
2020-08-03
DOI
10.3390/cancers12082135
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma
- (2019) Motonari Nomura et al. JNCI-Journal of the National Cancer Institute
- Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review
- (2019) Milea J. M. Timbergen et al. Frontiers in Oncology
- Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
- (2019) Maud Toulmonde et al. LANCET ONCOLOGY
- Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression
- (2019) Vasiliki Siozopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis
- (2018) Chiara Colombo et al. GENES CHROMOSOMES & CANCER
- Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study
- (2018) Milea J. M. Timbergen et al. QUALITY OF LIFE RESEARCH
- Surgical excision versus observation as initial management of desmoid tumors: A population based study
- (2018) Benjamin Turner et al. EJSO
- Sorafenib for Advanced and Refractory Desmoid Tumors
- (2018) Mrinal M. Gounder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
- (2017) Bernd Kasper et al. EUROPEAN JOURNAL OF CANCER
- Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
- (2017) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Percutaneous Cryoablation of Extraabdominal Desmoid Tumors: A 10-Year Experience
- (2016) John J. Schmitz et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01)
- (2016) Bernd Kasper et al. ANNALS OF SURGICAL ONCOLOGY
- Chemoprevention of familial adenomatous polyposis
- (2016) Patrick M. Lynch Familial Cancer
- Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis
- (2016) Kyong-Hwa Park et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Targeting theNotch pathway: A potential therapeutic approach for desmoid tumors
- (2015) Hui Shang et al. CANCER
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis
- (2015) Marco Fiore et al. EUROPEAN JOURNAL OF CANCER
- Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients
- (2015) C. Colombo et al. EUROPEAN JOURNAL OF CANCER
- Near universal detection of alterations inCTNNB1and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis
- (2015) Aimee M. Crago et al. GENES CHROMOSOMES & CANCER
- Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status
- (2015) Yoshihiro Nishida et al. International Journal of Clinical Oncology
- Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2
- (2015) Jon M. Carthy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognostic Value of CTNNB1 Gene Mutation in Primary Sporadic Aggressive Fibromatosis
- (2014) Danique L. M. van Broekhoven et al. ANNALS OF SURGICAL ONCOLOGY
- A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral -Secretase Inhibitor PF-03084014
- (2014) W. A. Messersmith et al. CLINICAL CANCER RESEARCH
- Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis
- (2014) Fábio Guilherme Campos et al. Familial Cancer
- Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998)
- (2013) R. B. Keus et al. ANNALS OF ONCOLOGY
- A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis
- (2013) Aimeé M. Crago et al. ANNALS OF SURGERY
- CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence
- (2013) Chiara Colombo et al. CANCER
- NSAIDs Inhibit Tumorigenesis, but How?
- (2013) Evrim Gurpinar et al. CLINICAL CANCER RESEARCH
- Celecoxib Inhibits β-Catenin-Dependent Survival of the Human Osteosarcoma MG-63 Cell Line
- (2013) J-J Xia et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- The treatment of desmoid tumors: a stepwise clinical approach
- (2012) S. Bonvalot et al. ANNALS OF ONCOLOGY
- Signal transduction pathway analysis in desmoid-type fibromatosis: Transforming growth factor-β, COX2 and sex steroid receptors
- (2012) Nicholas A. Mignemi et al. CANCER SCIENCE
- Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)
- (2011) D. Garbay et al. ANNALS OF ONCOLOGY
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- (2011) M. M. Gounder et al. CLINICAL CANCER RESEARCH
- Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review
- (2011) D. Bocale et al. Colorectal Disease
- Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation
- (2011) Sébastien Salas et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversible SUMOylation of TBL1-TBLR1 Regulates β-Catenin-Mediated Wnt Signaling
- (2011) Hyo-Kyoung Choi et al. MOLECULAR CELL
- The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells
- (2011) Jonas Ungerbäck et al. PLoS One
- Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment
- (2009) Marco Fiore et al. ANNALS OF SURGICAL ONCOLOGY
- Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient
- (2009) Sylvie Bonvalot et al. ANNALS OF SURGICAL ONCOLOGY
- Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
- (2009) Anastasia Constantinidou et al. EUROPEAN JOURNAL OF CANCER
- Successful Treatment With Meloxicam, a Cyclooxygenase-2 Inhibitor, of Patients With Extra-Abdominal Desmoid Tumors: A Pilot Study
- (2009) Yoshihiro Nishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
- (2009) V. Rodilla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Outcomes for Desmoid Tumors Treated With Radiation Therapy
- (2008) B. Ashleigh Guadagnolo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts
- (2007) Giordano Stabellini et al. BIOMEDICINE & PHARMACOTHERAPY
- Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients
- (2007) S. Bonvalot et al. EJSO
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now